| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0007 |